MINOR DISEASE FEATURES IN NEUROFIBROMATOSIS TYPE-1 (NF1) AND THEIR POSSIBLE VALUE IN DIAGNOSIS OF NF1 IN CHILDREN LESS-THAN-OR-EQUAL-TO-6 YEARS AND CLINICALLY SUSPECTED OF HAVING NF1
Mh. Cnossen et al., MINOR DISEASE FEATURES IN NEUROFIBROMATOSIS TYPE-1 (NF1) AND THEIR POSSIBLE VALUE IN DIAGNOSIS OF NF1 IN CHILDREN LESS-THAN-OR-EQUAL-TO-6 YEARS AND CLINICALLY SUSPECTED OF HAVING NF1, Journal of Medical Genetics, 35(8), 1998, pp. 624-627
Objective - To establish the frequency of minor disease features in ch
ildren with neurofibromatosis type 1 (NF1) and to evaluate the value o
f minor disease features in children less than or equal to 6 years wit
h a suspected diagnosis of NF1, considering that the disease is virtua
lly 100% penetrant at 6 years of age. Design - During this 10 year, pr
ospective, multidisciplinary, follow up study, 209 children suspected
of having NF1 were examined; 150 were diagnosed with NF1 and 59 were n
ot. The present analysis included children in whom NF1 was considered
to be present at 6 years of age (n = 85) and children without NF1 at 6
years of age (n = 42). Results - The minor disease features macroceph
aly (52.9%), short stature (24.7%), hypertelorism (63.5%), and thorax
abnormalities (37.6%) were highly prevalent in children with NF1 and s
ignificantly associated with a diagnosis of NF1 at 6 years of age. In
addition, the mean number of minor disease features was significantly
higher in children with NF1 at 6 years of age compared to the group wi
thout a diagnosis at 6 years of age (mean 1.8 v 0.8, p < 0.001). Moreo
ver, children with three or more minor disease features were all diagn
osed with NF1 under the age of 6 years. Multivariate analysis using a
logistic regression model showed that macrocephaly, short stature, hyp
ertelorism, and thorax abnormalities were all independently associated
with the presence of NF1 at 6 years of age. Conclusion - In children
with insufficient diagnostic criteria aged less than or equal to 6 yea
rs, documentation of minor disease features may be a helpful aid in pr
edicting the diagnosis of NF1 in years to come.